Brand expansion is a key part of the company’s growth plan to secure intellectual property rights in the cannabis industry globally
TUCSON, AZ / ACCESSWIRE / April 7, 2022 / WEED, Inc. (OTCQB:BUDZ) (“WEED” or the “Company”), a US-based global cannabis and hemp bio-research company focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases. , announced today that it is focused on growing its portfolio of trademarked brands in the industry. WEED, Inc. already holds a federal registration for its WEED® trademark with the United States Patent and Trademark Office (USPTO) and the European Community Trademark Office for a variety of smoking accessories (cartridges and vaporizer gaskets). WEED, Inc. is now pursuing a series of federal applications for its trademarks WEED®, PANAMA RED™ and ACAPULCO GOLD™ to cover a wide range of products (rolling papers, grinders, tobacco pipes) and services, including nutritional supplements for medicated preparations. for cats, dogs and pets, namely for the management of joint mobility; it also provides education, information and news about cannabis health and medical research, social media software, and organizes concerts and festivals.
“WEED festivals in the scope and range of Woodstock and US festivals from the earliest days have always been on my mind and goals as I was a national concert promoter and producer during the 1970s and 1980,” said our CEO, Glenn E. Martin.
Expanded federal registration of its trademarks is part of WEED’s broader effort. to expand its Intellectual Property (IP) Brand Division into a variety of goods and services outside of those offered as part of its core goods and services, namely the development of Cannabis products for adults and baby care health derivatives of cannabis. Among other measures, WEED, Inc. has sought to expand its registered trademark WEED® and other associated trademarks, including PANAMA RED™, ACAPULCO GOLD™ and WEED RULES!™ for goods and services including cosmetics and cleaning preparations, paper goods and printed material, and natural agricultural products among others through the filing of multiple trademark applications with the USPTO. “By protecting and expanding existing trademark rights and acquiring additional intellectual property rights, we will strengthen WEED, Inc.’s brand recognition and position as a leader in the cannabis industry and create shareholder value beyond that created by the company’s core business.” comments WEED, Inc. President/CEO Glenn E. Martin. “We believe that most of the discoveries in cannabis and hemp have yet to be found. We believe that these exciting times will change global health around the world! Leading WEED scientists are already working on new breeding programs, genetic modifications, formulations, and drug delivery systems for humans. and pets.”
2021/2022 WEED, Inc. Subsidiaries Past Comments
WEED Israel (Cannabis) Ltd. “After more than 2 years of suspending human clinical trials and product development due to COVID, WEED Israel is ready and eager to develop our global brands in pharmaceutical and non-pharmaceutical categories, starting with women’s health and diseases of veterans (PTSD) to green and healthy alternative medicines,” said Elliot Kwestel, managing director of WEED Israel (Cannabis) Ltd. based on the outskirts of Jerusalem. Kwestel further commented, “WEED Israel seeks to enrich and expand our clinical trials with THC and cannabinoid studies to promote healthy living for generations to come.”
WEED Australia Ltd. Y The Cannabis Institute of Australia (CIA), our non-profit Australian branch, based in Queensland, on the Gold Coast. Managing Director Patrick Brodnik stated: “With the new rules governing cannabis and hemp in Australia and the announcement of the 1St. February 2021 to allow over-the-counter CBD medications in pharmacies, the timing is perfect to begin our clinical trials in Israel and Australia to bring new healing products to market as we close COVID mandates this year. CEO Brodnik continues: “This year 2022, the future of global cannabis and hemp decriminalization will prove to be a huge step forward for cannabis legalization worldwide.”
GRASS Hong Kong Ltd. Director Nicole Breen agrees: “The pandemic has affected us all around the world. Healing our planet with natural therapies, treatments and eventual ‘cures’ using nature’s own Cannabaceae plant with its many properties, both with high Tetrahydrocannabinol (THC) content like cannabidiol (CBD) compounds, I believe will change the force of medicine forever in the years to come. We look forward to an exciting end to the year and a prosperous 2022.”
Caution Regarding Cannabis Operations in the United States
Investors should be aware that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. While legal in certain states, cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving income generated from, or with the intent to further, commercial cannabis-related activities in the United States may form the basis for prosecution under applicable United States federal money laundering laws. Investors should carefully read the risk factors and disclosures contained in our offering circular before making any decision to invest in our company.
This press release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this news release can be identified by the use of words such as “may”, “would”, “could”, “will”, “likely”, “expects”, “anticipates”, “believes”, “intends”. “, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and include statements regarding future income and earnings. Forward-looking information is not a guarantee of future performance and is based on a number of management’s estimates and assumptions in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions regarding the current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, forward-looking information should not be unduly relied upon because the Company cannot guarantee that they will prove to be correct. Actual results and developments may differ materially from those contemplated in these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Statements in this press release are made as of the date of this release. The Company disclaims any intention or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
The information is provided for convenience only, is not investment advice and should not be relied upon when considering an investment in WEED, Inc. No representation or warranty, express or implied, is made as to the accuracy or completeness of the information. any information contained in this document. and any investment decision should be based solely on the information contained in the offering circular and related materials, and independent investor research. No representation or warranty, express or implied, is made as to the future performance of any investment in WEED, Inc. or that investors will achieve or are likely to achieve favorable results, obtain any profit or avoid incurring a loss on their investment. investment. In addition, prospective investors are encouraged to consult with their financial, tax, accounting or other advisors to determine if an investment in WEED, Inc. is right for them.
Glenn E. Martin, CEO
SOURCE: GRASS, Inc.
See the source version at accesswire.com: